9999999997-17-001575.txt : 20170303 9999999997-17-001575.hdr.sgml : 20170303 20170303104438 ACCESSION NUMBER: 9999999997-17-001575 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170303 DATE AS OF CHANGE: 20170303 20170303 20170303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 17661868 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*, T*)25%3T8-"B @(" @(" @#0HR M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T M:" V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G )./094P C$+ P<#%LP(# @-C$R(#7!E+T]B:E-T;3X^"AS77QUL;G.#7,1##C_(AY, MRFPS2UP\MI6QZQV;EU6N,^=Z:B0I5/3=ZBQ=CXMM9H"SV)K\$?]SV-R/YM6;%?O:NXBTYT;2CG4ON[8EUNTF++GM)B7-3I\7N:5K6]V>D*/'G6A09- M0_JAVPPA4=?+;TN"DNK%.&5'>7CTQN[JI0PXT IX8_N+8I[G09-#&>_MM\_^ M4E*V3]IAJ" 4 I2*W/:BHC_6=)<6= M7[;GD8W(C[Y.I\M%#5[K;\];?1;%\"V*7'T,Q7]2Z%^@,)*?@_"C_$E^SI_X M#_Y.B^9!^YQ FN$E!L]W-_<^B8Z_EB?BL)NYZX<<-'Q%+96GFB;O/?I.'%'/ MOCTRV-,B6^[/M7;]^_=S_/..Q[\"# 8J8JW#0IE;F1S=')E86T-96YD;V)J M#3$T(# @;V)J#3P\+T9I;'1E\ @ MQ[HAD K<)/_][4K"/ZA]G3EWBH4L[7[[:??3YNKF@9&G=O0Q&UUE&2>,9)L1 MX\2'?_"5^B3V$YJ$)'L>^>0)_F<%/EY'#G&S?T8LI#XC'J,L(MGUR*.^SU)< M8P>OH[^<;ZME-G>]D*;.-7EPO8C&3N92YDPS,SNWD\3]._L\\B8TCJ-3F_[$ MVL0!VGR8S[[=+[.E"ZM#,$"FJVL"3@(ZR8_D&R^_DTNX47 M2Q9LG$0_QV-X1X_9ISGIV0*>YI8=,IUEY&Y!6!H@^=P)K4$XB#"Z'"N#M#&Z #E:*'.AB X.BN&Z_HE!@,/!A$9;%!BH2DQ7_\>7LA @.AZ/([\ Y-D M61>4M+OULYLXLNM$2?*:Y"\OE2SR3AK\,0W@;/8!A+U59JTV-=G5I5#D?@?4 M\G#M<:+$=S>"&MJY\!!M)^LGM"S>.E&W$G;8/#.V!U$U&_*BQ _9[%KRI/*Z M:PE,%4V]D:6H=;Y :1P@L0.DT$#J9.YB^E6D4VZ($/+N&9*$.\*%1]V1C9YN M7 9/161]\FZ6 @$ 5': NJAVI8N: 29EEW$C8O7[7^-LQ9@9J-F X 1]Q6U>#\SP(%EG(; M-<##N"]S! ;W40]%!J8.E64'QU7Q,6^-324@_5I1=[D) P@Z:$^*Y*#R+-T8 MAK6>* :"I"M]_A2KL_/<^8.[D%N!7_ MOB(@VRLXK^=GH0H<-@KXJ?-:OV@?F%H3QWKJSS!-!ZKDV9&IH'U98W(LE!!E M@P8"!XMQV5N-'#-I\$^+;GPH;7!P_F299MZ)R#?Z0&>41!%_=-:/[J,3/KIC M[?!:_I!:*,#9K%$OCB>]36YK"O@$!H; MHYP;:' X(!G@;D]_"D1APABB-JHQKSK83=-?U\%QZ@P[B*IJ7E%(15]3K[*J M=$!KT=\0-$HOA>';BTJ)2NA4!QK0NZ$"0)BC[J1!!CK L-Y>A))-V9+V111: M,#X8S@Z='5SN!&[^/ 5\.H[65>>H2'2K=I)WS.LV=DA M]5UL]BJH84S-3*'2P[PQY0_:I[X!LH3>X.6"1&Q5LWO:#FY3SP+9WZEGD8": M!2E*2,!]1VL3M(C0M#C\BL=7P#G^%$",IT(%B3)$J&V!1EZRQ7YE"P1.V] F M$F/B:V\BNII<02>%O_S: NKS_T7AZ72XU.F!A_W@-#L':KRPZ3@#7=/Y*%O4 M@W%_71T)A,F:A*;LC*"QV#CO1>1('\:0^JK=00Y@*=@V#ZU%[K/M8 M_?X9W['%H.;=3B_P"]3&D?UZ-!1!UPN5@/9A4)JE;6_AI!O0L@G0PK2_E?3G M011*='"FT#W!7SDNI#_\,BAWD[*3G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U M+C0M8S P-B X,"XQ-3DX,C4L(#(P,38O,#DO,38M,#,Z,S$Z,#@@(" @(" @ M("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9" M($5X96QI>&ES($EN8RX@ M,S0W-3,N9&]C>#PO&UP.D-R96%T941A=&4^,C Q-RTP M,RTP,U0Q,#HT,SHU-RTP-3HP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @ M(#QX;7 Z0W)E871O&UP34TZ26YS=&%N8V5) M1#YU=6ED.C S,S W8C!B+30S9#0M-&)E8BTY,35C+3$S.&4X8C(W.35D93PO M>&UP34TZ26YS=&%N8V5)1#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @ M(#POJ'5!:DZ@8:*8,WZ,W8#>MLR:PG_5^_R_ (8/1 8-"F5N9'-TF4@,3 O5'EP92]84F5F+U=;,2 R(#%=/CYS=')E86T-"FC>8F( B9& M[O,,3 R,;4"";S608.@%<86 $D^30%P&1B#!]!](,#( !!@ ?DL%&PT*96YD E